Glioblastoma is the most common primary CNS tumor and is the most aggressive neoplasm among gliomas. Glioblastoma represents a highly unmet medical need due to its dismal prognosis, meaningful disability and lack of new agents since temozolomide concurrent with and adjuvant to radiotherapy became the standard therapy
Lamberti G., Franceschi E., Brandes A.A. (2018). The burden of oncology promises not kept in glioblastoma. FUTURE NEUROLOGY, 13(1), 1-4 [10.2217/fnl-2017-0033].
The burden of oncology promises not kept in glioblastoma
Lamberti G.;
2018
Abstract
Glioblastoma is the most common primary CNS tumor and is the most aggressive neoplasm among gliomas. Glioblastoma represents a highly unmet medical need due to its dismal prognosis, meaningful disability and lack of new agents since temozolomide concurrent with and adjuvant to radiotherapy became the standard therapyFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
